LON:HVO

hVIVO (HVO) Share Forecast, Price & News

GBX 16.38

-0.22 (-1.33%)

(As of 05/26/2023 04:34 PM ET)

Compare

Today's Range: 16.25
▼
17
50-Day Range: 14.15
▼
19
52-Week Range: 9.20
▼
23.40

Volume: 690,198 shs
Average Volume: 2.27 million shs
Market Capitalization: £109.92 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Dividend Insider Trades Headlines

About hVIVO (LON:HVO) Stock

hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services.

hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.

Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Stock News Headlines

May 16, 2023 | finance.yahoo.com

One hVIVO Insider Raised Their Stake In The Previous Year

May 16, 2023 | finance.yahoo.com

One hVIVO Insider Raised Their Stake In The Previous Year \

May 28, 2023 | Behind the Markets (Ad)

NOTICE: Your retirement is in immediate danger

Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>

April 30, 2023 | finance.yahoo.com

Despite shrinking by UK£15m in the past week, hVIVO (LON:HVO) shareholders are still up 100% over 3 years

April 27, 2023 | americanbankingnews.com

hVIVO plc (HVO) to Issue Dividend of GBX 0.45 on June 9th

April 25, 2023 | finance.yahoo.com

hVIVO reveals audited results for "transformational" 2022

March 9, 2023 | finance.yahoo.com

hVIVO plc (HVO.L)

March 8, 2023 | finance.yahoo.com

Is hVIVO plc (LON:HVO) Worth UK£0.2 Based On Its Intrinsic Value?

May 28, 2023 | Behind the Markets (Ad)

NOTICE: Your retirement is in immediate danger

February 12, 2023 | msn.com

This ex-penny stock is up 111% in 6 weeks. Should I buy more?

February 4, 2023 | msn.com

3 no-brainer UK shares to buy in February

February 3, 2023 | finance.yahoo.com

We Might See A Profit From hVIVO plc (LON:HVO) Soon

January 26, 2023 | lse.co.uk

Hvivo Plc Share Price (HVO.GB.PL)

January 10, 2023 | finance.yahoo.com

Following a 34% decline over last year, recent gains may please hVIVO plc (LON:HVO) institutional owners

January 7, 2023 | fool.co.uk

1 penny stock I’m buying right now!

December 8, 2022 | finance.yahoo.com

Is hVIVO plc (LON:HVO) Potentially Undervalued?

December 7, 2022 | uk.finance.yahoo.com

1 penny stock under 13p I’d snap up right now

November 17, 2022 | finance.yahoo.com

Investors in hVIVO (LON:HVO) have unfortunately lost 52% over the last year

October 26, 2022 | proactiveinvestors.com

hVIVO is a world leader in testing infectious and respiratory disease products using human challenge clinical trials

December 16, 2020 | lse.co.uk

Open Orphan Share Chat

January 20, 2020 | www.lse.co.uk

Hvivo Plc Share Chat

January 17, 2020 | www.lse.co.uk

Open Orphan Takeover Of hVIVO Now Wholly Unconditional

January 14, 2020 | www.lse.co.uk

Open Orphan To Mount Compulsory Buyout To Get hVIVO Deal Over Line

January 6, 2020 | www.lse.co.uk

Hvivo Share News (HVO)

December 31, 2019 | www.lse.co.uk

Open Orphan Meets Acceptance Condition For Merger With hVIVO

December 19, 2019 | www.finanznachrichten.de

HVIVO PLC

October 10, 2019 | finance.yahoo.com

Can hVIVO (LON:HVO) Afford To Invest In Growth?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Company Calendar

Last Earnings: 4/19/2018
Ex-Dividend for 6/9 Dividend: 5/04/2023
Today: 5/28/2023
Dividend Payable: 6/09/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:HVO
Previous Symbol: LON:RVG
CUSIP: N/A
CIK: N/A
Web: hvivo.com
Phone: +44-20-77561300
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 23.94
P/E Growth: N/A
Net Income: £-1,060,000.00
Net Margins: -1.53%
Pretax Margin: N/A
Return on Equity: -3.80%
Return on Assets: 8.20%

Debt

Debt-to-Equity Ratio: 7.73
Current Ratio: 1.42
Quick Ratio: 1.16

Sales & Book Value

Annual Sales: £50.70 million
Price / Sales: 2.17
Cash Flow: GBX 3.32 per share
Price / Cash Flow: 4.94
Book Value: GBX 3 per share
Price / Book: 5.46

Miscellaneous

Outstanding Shares: 671,048,000
Free Float: N/A
Market Cap: £109.92 million
Optionable: Not Optionable
Beta: 1.10

Key Executives

Dr. Yamin Mohammed Khan Ph.D. (Age 54)
CEO & Director

Mr. Stephen Pinkerton
CFO & Exec. Director

Mr. Andrew Catchpole
Chief Scientific Officer

Dr. Maurice N. Treacy Ph.D.
Chief Commercial Officer

Ms. Teja Marathe-Sarvadikar
Head of QA

Key Competitors

View All Competitors

HVO Stock - Frequently Asked Questions

How have HVO shares performed in 2023?: hVIVO's stock was trading at GBX 10 on January 1st, 2023. Since then, HVO stock has increased by 63.8% and is now trading at GBX 16.38.
View the best growth stocks for 2023 here.
How were hVIVO's earnings last quarter?: hVIVO plc (LON:HVO) posted its earnings results on Thursday, April, 19th. The company reported ($16.50) earnings per share for the quarter, missing analysts' consensus estimates of ($10.90) by $5.60. hVIVO had a negative trailing twelve-month return on equity of 3.80% and a negative net margin of 1.53%.
How often does hVIVO pay dividends? What is the dividend yield for hVIVO?: hVIVO announced a dividend on Tuesday, April 25th. Shareholders of record on Thursday, May 4th will be paid a dividend of GBX 0.45 per share on Friday, June 9th. This represents a dividend yield of 2.65%. The ex-dividend date is Thursday, May 4th. The official announcement can be viewed at this link.
Read our dividend analysis for HVO.
What other stocks do shareholders of hVIVO own?: Based on aggregate information from My MarketBeat watchlists, some companies that other hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY).

What is hVIVO's stock symbol?: hVIVO trades on the London Stock Exchange (LON) under the ticker symbol "HVO."
How do I buy shares of hVIVO?: Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is hVIVO's stock price today?: One share of HVO stock can currently be purchased for approximately GBX 16.38.
How much money does hVIVO make?: hVIVO (LON:HVO) has a market capitalization of £109.92 million and generates £50.70 million in revenue each year.
How can I contact hVIVO?: hVIVO's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The official website for the company is hvivo.com. The company can be reached via phone at +44-20-77561300.

This page (LON:HVO) was last updated on 5/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial